Avricore Health Inc.
AVCR.V
TSX
Weiss Ratings | AVCR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | D | |||
Rating Factors | AVCR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | AVCR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.78 | |||
Price History | AVCR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | -25.00% | |||
60-Day Total Return | -30.77% | |||
90-Day Total Return | -67.86% | |||
Year to Date Total Return | -25.00% | |||
1-Year Total Return | -66.67% | |||
2-Year Total Return | -85.00% | |||
3-Year Total Return | -65.38% | |||
5-Year Total Return | 125.00% | |||
52-Week High % Change | -86.57% | |||
52-Week Low % Change | 28.57% | |||
Price | AVCR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.34 | |||
52-Week Low Price | $0.04 | |||
52-Week Low Price (Date) | Mar 11, 2025 | |||
52-Week High Price (Date) | Aug 29, 2024 | |||
Valuation | AVCR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 3.16M | |||
Enterprise Value | 2.61M | |||
Price/Earnings (TTM) | 56.25 | |||
Earnings Per Share (TTM) | 0.00 | |||
Earnings Per Share Growth | -110.81% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 1.30 | |||
Price/Book (Q) | 2.46 | |||
Enterprise Value/Revenue (TTM) | 0.75 | |||
Price | $0.05 | |||
Enterprise Value/EBITDA (TTM) | 5.65 | |||
Enterprise Value/EBIT | 20.65 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | AVCR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 100.40M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | AVCR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 604-773-8943 | |||
Address | 789 West Pender Street Vancouver, BC V6C 1H2 | |||
Website | avricore.com | |||
Country | Canada | |||
Year Founded | 1996 | |||
Profitability | AVCR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 3.64% | |||
Profit Margin | 2.21% | |||
Management Effectiveness | AVCR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 3.91% | |||
Return on Equity | 4.85% | |||
Income Statement | AVCR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 3.47M | |||
Total Revenue (TTM) | 3.47M | |||
Revenue Per Share | $0.04 | |||
Gross Profit (TTM) | 1.32M | |||
EBITDA (TTM) | 463.10K | |||
EBIT (TTM) | 126.60K | |||
Net Income (TTM) | 77.00K | |||
Net Income Avl. to Common (TTM) | 77.00K | |||
Total Revenue Growth (Q YOY) | 23.27% | |||
Earnings Growth (Q YOY) | 38.21% | |||
EPS Diluted (TTM) | 0.00 | |||
EPS Diluted Growth (Q YOY) | 38.10% | |||
Balance Sheet | AVCR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 585.20K | |||
Cash Per Share (Q) | $0.01 | |||
Total Current Assets (Q) | 1.04M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 1.84M | |||
Current Ratio (Q) | 2.621 | |||
Book Value Per Share (Q) | $0.02 | |||
Total Assets (Q) | 2.24M | |||
Total Current Liabilities (Q) | 396.30K | |||
Total Debt (Q) | 0.00 | |||
Total Liabilities (Q) | 396.30K | |||
Total Common Equity (Q) | 1.84M | |||
Cash Flow | AVCR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -407.40K | |||
Cash from Financing (TTM) | 28.50K | |||
Net Change in Cash (TTM) | 289.20K | |||
Levered Free Cash Flow (TTM) | 270.20K | |||
Cash from Operations (TTM) | 668.10K | |||